企業プロフィール
Dermata Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- DRMA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
1.46 USD (0.00%)
終値
最終更新: 2026年8月17日
5.47M USD
時価総額
株価変動の要因
The latest monitored headline was “Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules”. DRMA was little changed in the corresponding trading session, closing at $1.46 on Aug 17, 2026.
企業概要
Consumer Skincare Company
Dermata Therapeutics has shifted from clinical-stage dermatology development toward a direct-to-consumer commercial skincare strategy.
Tome Brand
Tome is designed as a professional-style at-home skincare line built around simplified, periodic treatments rather than multi-step daily regimens.
Foundational Treatment
The first product is a once-weekly mask intended to support skin renewal and serve as the foundation of the broader Tome portfolio.
今後のカタリスト
- Commercial launch of Tome Foundational Treatment on August 25, 2026.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。